Spain to trial mixing COVID-19 vaccines

Trial in Spain aims to recruit 600 people to determine within 28 days whether a second dose of the Pfizer vaccine can be given to patients who have received the AstraZeneca vaccine. A British study on mixing vaccines was expanded last week to include Moderna and Novavax vaccines.

Source:

Reuters Health